You are here: Industry Insights > vaccine

News List

Panav Bio-Tech Introduces Classical Swine Fever expressbpd
December 05, 2018
Himmvac Hog Cholera (T/C) Vaccine by Panav Bio-Tech is the vaccine that is made using Bovine Kidney Cell culture and provides protection against the Hog cholera or classical swine fever
FluGen’s broadly protective flu vaccine clears phase 1 fiercepharma
December 04, 2018
Every year, scientists have to choose which strains of flu virus to include in the coming season's flu shots, and when the vaccine strains don't match the circulating strains, vaccine effectiveness can be much lower.
NIH grants IDT 10-year vaccine manufacturing contract fiercepharma
December 04, 2018
IDT Biologika has won a 10-year contract worth up to $80 million from the NIH’s National Institute of Allergy and Infectious Diseases to make vaccines and biologics for infectious diseases.
Most Bills Enacted Into Law Limit Vaccine Exemptions drugs
November 30, 2018
Most proposed bills in state legislatures from 2011 to 2017 sought to expand access to immunization exemptions, but the majority of bills enacted into law limited exemptions......
DNAtrix, Valo Therapeutics Enter Strategic R&D Pact contractpharma
November 28, 2018
DNAtrix and Valo Therapeutics entered an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's antigenic peptide technology.
Protection against yellow fever provided by fractional-dose vaccination europeanpharmaceuticalreview
November 28, 2018
Researchers at Leiden University Medical Center have identified how fractional-dose yellow fever vaccinations protect against the condition for ten years…
Marken, RareChannels Announce Collaboration contractpharma
November 27, 2018
Marken announced a new collaboration with RareChannels, a global web-based reference which allows manufactures of rare disease therapies and their affiliates to find customized logistic solutions.
FDA takes action against Sanofi biospectrumasia
November 20, 2018
Philippines' Food and Drug Administration (FDA) has suspended the sale of the controversial Dengvaxia dengue vaccine for a year.
MPs voice concern over clinical trials transparency pharmatimes
November 01, 2018
MPs have expressed concern that nearly half of clinical trials in the UK fail to publish their results, “presenting risks to human health and increasing research wastage”...
Vaccine coverage falls by 6.2% since last year pharmafile
October 31, 2018
Despite the severity of the flu season, just 37.1% of American adults received the flu vaccine this year, according to information from the Centers for Disease Control and Prevention (CDC)....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page